Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
64
SMFG Quote, Financials, Valuation and Earnings
Last price:
$14.53
Seasonality move
:
0.42%
Day range:
$14.28 - $14.43
52-week range:
$10.74 - $16.74
Dividend yield:
2.85%
P/E ratio:
12.08x
P/S ratio:
2.81x
P/B ratio:
0.94x
Volume:
2M
Avg. volume:
2.8M
1-year change:
19.38%
Market cap:
$92.6B
Revenue:
$33.3B
EPS (TTM):
$1.19
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.8B | $30.5B | $27.5B | $30.7B | $33.3B | |
| Revenue Growth (YoY) | 1.1% | 5.95% | -9.67% | 11.54% | 8.26% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15B | $14.7B | $13.2B | $15.8B | $15.8B | |
| Other Inc / (Exp) | $679.7M | $2.2B | $2.2B | -$5.1M | -$4.8M | |
| Operating Expenses | $16.3B | $15.5B | $14.2B | $15B | $15.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.3B | $8.3B | $8.1B | $9.3B | $11.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5B | $1.9B | $2.1B | $2.6B | $3.4B | |
| Net Income to Company | $6.3B | $8.3B | $8.1B | $9.3B | $11.2B | |
| Minority Interest in Earnings | -$29M | -$75M | -$77.6M | -$39.8M | -$58.3M | |
| Net Income to Common Excl Extra Items | $4.8B | $6.3B | $6B | $6.7B | $7.7B | |
| Basic EPS (Cont. Ops) | $0.71 | $0.92 | $0.87 | $1.00 | $1.19 | |
| Diluted EPS (Cont. Ops) | $0.71 | $0.92 | $0.87 | $1.00 | $1.19 | |
| Weighted Average Basic Share | $6.9B | $6.9B | $6.8B | $6.6B | $6.5B | |
| Weighted Average Diluted Share | $6.9B | $6.9B | $6.8B | $6.6B | $6.5B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $11.2B | $11.7B | $23.4B | $39.3B | $41.3B | |
| Revenue (Reported) | $28.8B | $30.5B | $27.5B | $30.7B | $33.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $11.2B | $11.7B | $23.4B | $39.3B | $41.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | $7.9B | $6.5B | $8.8B | $8.2B | |
| Revenue Growth (YoY) | 1.34% | 12.31% | -18.11% | 35.8% | -6.6% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.9B | $2.8B | $2.7B | $4.4B | $4.1B | |
| Other Inc / (Exp) | $680.3M | $2.2B | $2.3B | -$4.9M | -$4.8M | |
| Operating Expenses | $2.6B | $1.9B | $2.3B | $4.3B | $4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $804.1M | $580.5M | $517.4M | $1.7B | $573.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $44.3M | -$153.4M | $194M | $576.7M | $282.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$15M | -$29.4M | -$21.9M | -$14.2M | -$15.9M | |
| Net Income to Common Excl Extra Items | $744.8M | $704.4M | $301.5M | $1.1B | $275.6M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.10 | $0.05 | $0.17 | $0.05 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.10 | $0.05 | $0.17 | $0.05 | |
| Weighted Average Basic Share | $6.9B | $6.9B | $6.8B | $6.6B | $6.5B | |
| Weighted Average Diluted Share | $6.9B | $6.9B | $6.8B | $6.6B | $6.5B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.8B | $1.6B | $6.6B | $9.7B | $7.5B | |
| Revenue (Reported) | $7B | $7.9B | $6.5B | $8.8B | $8.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.8B | $1.6B | $6.6B | $9.7B | $7.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.8B | $30.5B | $27.5B | $30.7B | $33.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15B | $14.7B | $13.2B | $15.8B | $15.8B | |
| Other Inc / (Exp) | $648.1M | $2.2B | $2.3B | -$4.9M | -$4.8M | |
| Operating Expenses | $14.7B | $13.8B | $12.7B | $15B | $15.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.3B | $8.4B | $8.1B | $9.3B | $11.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5B | $1.9B | $2.1B | $2.6B | $3.4B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$28.9M | -$74.5M | -$77.6M | -$40.1M | -$58.4M | |
| Net Income to Common Excl Extra Items | $4.8B | $6.3B | $5.9B | $6.7B | $7.7B | |
| Basic EPS (Cont. Ops) | $0.71 | $0.93 | $0.87 | $1.01 | $1.19 | |
| Diluted EPS (Cont. Ops) | $0.71 | $0.93 | $0.87 | $1.01 | $1.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $11.2B | $11.7B | $23.3B | $39.3B | $41.3B | |
| Revenue (Reported) | $28.8B | $30.5B | $27.5B | $30.7B | $33.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $11.2B | $11.7B | $23.3B | $39.3B | $41.3B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.5B | $27.5B | $30.7B | $33.3B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $14.7B | $13.2B | $15.8B | $15.8B | -- | |
| Other Inc / (Exp) | $2.2B | $2.3B | -$4.9M | -$4.8M | -- | |
| Operating Expenses | $13.8B | $12.7B | $15B | $15.6B | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.4B | $8.1B | $9.3B | $11.2B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9B | $2.1B | $2.6B | $3.4B | -- | |
| Net Income to Company | $4.6B | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$74.5M | -$77.6M | -$40.1M | -$58.4M | -- | |
| Net Income to Common Excl Extra Items | $6.3B | $5.9B | $6.7B | $7.7B | -- | |
| Basic EPS (Cont. Ops) | $0.93 | $0.87 | $1.01 | $1.19 | -- | |
| Diluted EPS (Cont. Ops) | $0.93 | $0.87 | $1.01 | $1.19 | -- | |
| Weighted Average Basic Share | $27.4B | $27.3B | $26.6B | $26B | -- | |
| Weighted Average Diluted Share | $27.4B | $27.3B | $26.6B | $26B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $11.7B | $23.3B | $39.3B | $41.3B | -- | |
| Revenue (Reported) | $30.5B | $27.5B | $30.7B | $33.3B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $11.7B | $23.3B | $39.3B | $41.3B | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $657.8B | $612.8B | $569.7B | $516.3B | $505.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $742.1B | $693.8B | $646.8B | $607.4B | $615B | |
| Property Plant And Equipment | $13.2B | $11.9B | $11.2B | $6.7B | $6.7B | |
| Long-Term Investments | $401.8B | $390.2B | $324.7B | $328.6B | $390B | |
| Goodwill | $1.3B | $2.6B | $2.1B | $1.8B | $1.5B | |
| Other Intangibles | $5.4B | $4.7B | $4.7B | $4.7B | $5.3B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.2T | $2.1T | $2T | $2T | $2T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $12.4B | $9.3B | $19.3B | $20.7B | $29.3B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $193.1B | $203.2B | $180.9B | $174.7B | $226.6B | |
| Long-Term Debt | $247.5B | $238.6B | $183.6B | $189.5B | $170B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1T | $2T | $1.9T | $1.9T | $1.9T | |
| Common Stock | $21.2B | $19.2B | $17.6B | $15.5B | $15.7B | |
| Other Common Equity Adj | $19.1B | $12.7B | $10.2B | $15.5B | $11.8B | |
| Common Equity | $107.2B | $99.1B | $95.2B | $96.9B | $98.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $642.1M | $800M | $821.8M | $917.9M | $917.6M | |
| Total Equity | $107.9B | $99.9B | $96B | $97.8B | $99.2B | |
| Total Liabilities and Equity | $2.2T | $2.1T | $2T | $2T | $2T | |
| Cash and Short Terms | $657.8B | $612.8B | $569.7B | $516.3B | $505.2B | |
| Total Debt | $275.2B | $263.2B | $220.5B | $226.3B | $217.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $657.8B | $612.8B | $569.7B | $516.3B | $505.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $742.1B | $693.8B | $646.8B | $607.4B | $615B | |
| Property Plant And Equipment | $13.2B | $11.9B | $11.2B | $6.7B | $6.7B | |
| Long-Term Investments | $401.8B | $390.2B | $324.7B | $328.6B | $390B | |
| Goodwill | $1.3B | $2.6B | $2.1B | $1.8B | $1.5B | |
| Other Intangibles | $5.4B | $4.7B | $4.7B | $4.7B | $5.3B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.2T | $2.1T | $2T | $2T | $2T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $12.4B | $9.3B | $19.3B | $20.7B | $29.3B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $193.1B | $203.2B | $180.9B | $174.7B | $226.6B | |
| Long-Term Debt | $247.5B | $238.6B | $183.6B | $189.5B | $170B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1T | $2T | $1.9T | $1.9T | $1.9T | |
| Common Stock | $21.2B | $19.2B | $17.6B | $15.5B | $15.7B | |
| Other Common Equity Adj | $19.1B | $12.7B | $10.2B | $15.5B | $11.8B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $642.1M | $800M | $821.8M | $917.9M | $917.6M | |
| Total Equity | $107.9B | $99.9B | $96B | $97.8B | $99.2B | |
| Total Liabilities and Equity | $2.2T | $2.1T | $2T | $2T | $2T | |
| Cash and Short Terms | $657.8B | $612.8B | $569.7B | $516.3B | $505.2B | |
| Total Debt | $275.2B | $263.2B | $220.5B | $226.3B | $217.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.3B | $8.3B | $8.1B | $9.3B | $11.2B | |
| Depreciation & Amoritzation | $2.1B | $2.2B | $2B | $2B | $1.8B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$36.6M | $233.8M | $154.2M | $334.6M | -$111.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $177.3B | $13.8B | -$43.7B | $4.5B | $32.6B | |
| Capital Expenditures | $3.1B | $2.6B | $2.2B | $2.7B | $2.4B | |
| Cash Acquisitions | -$40.6M | -$2B | -- | $362.1M | $6.3M | |
| Cash From Investing | -$72.4B | -$21.4B | $43.9B | -$6.4B | -$29.6B | |
| Dividends Paid (Ex Special Dividend) | -$2.5B | -$2.4B | -$2.2B | -$2.4B | -$2.7B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.8B | $1.6B | $1.6B | $6.8B | $4.3B | |
| Long-Term Debt Repaid | -$4.6B | -$3.5B | -$984.9M | -$207.9M | -$3.1B | |
| Repurchase of Common Stock | -$575.4K | -$659.2K | -$1B | -$1.5B | -$1.7B | |
| Other Financing Activities | -$10.8M | -$4.5M | -$12.4M | -$774.3M | -$39.1M | |
| Cash From Financing | -$5.3B | -$4.3B | -$2.6B | $1.9B | -$3.2B | |
| Beginning Cash (CF) | $529.2B | $595.1B | $487.5B | $456.4B | $435.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $99.6B | -$12B | -$2.4B | $32.2M | -$155.4M | |
| Ending Cash (CF) | $630.2B | $586.4B | $487.8B | $460B | $434.5B | |
| Levered Free Cash Flow | $174.2B | $11.2B | -$45.9B | $1.7B | $30.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $3.2B | $3.3B | $992.1M | $938.3M | $1.1B | |
| Cash Acquisitions | -$1.5B | -- | $251.9M | -$27M | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$953.1M | -$1.1B | -$1.2B | -$1.3B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.6B | -- | -- | -- | -- | |
| Depreciation & Amoritzation | $1.4B | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$10.3B | -- | -- | -- | -- | |
| Capital Expenditures | $1.1B | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $4.7B | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $848.1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2B | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$24M | -- | -- | -- | -- | |
| Cash From Financing | -$2.4B | -- | -- | -- | -- | |
| Beginning Cash (CF) | $650B | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | $451.4M | -- | -- | -- | -- | |
| Additions / Reductions | -$7.9B | -- | -- | -- | -- | |
| Ending Cash (CF) | $642.6B | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$11.4B | -- | -- | -- | -- | |
Get SMFG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SMFG
Sector
P/E ratio
12.08x
11.93x
PEG ratio
0.67x
0.38x
P/B ratio
0.94x
1.07x
Price / LTM sales
2.81x
2.53x
Growth Metrics
SMFG
Sector
Revenue growth
-6.6%
5.42%
Earnings growth
-74%
3.76%
Revenue (5-year growth)
3.16%
5.15%
Earnings forecast
--
$0.56
Profitability
SMFG
Sector
Profitability FY 2025
--
$137M
Return on invested capital
2.39%
5.33%
Return on assets
0.39%
0.98%
Return on equity
7.85%
9.28%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Aug
13
Balance Sheet
SMFG
Sector
Total cash
$505.2B
$473M
Short term investments
--
$233.7M
Total assets
$2T
$4B
Long term debt
$217.2B
$298.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 19
Semler Scientific [SMLR] is up 5.85% over the past day.
Sell
25
GLOB alert for May 19
Globant SA [GLOB] is up 4.02% over the past day.
Buy
94
HIMS alert for May 19
Hims & Hers Health [HIMS] is down 3.57% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
